Presynaptic noradrenergic alpha-receptors and modulation of 3H-noradrenaline release from rat brain synaptosomes

European Journal of Pharmacology
C D de LangenA H Mulder


The depolarization (15 mM K+)-induced release of 3H-NA from superfused rat brain synaptosomes and the effects of alpha-noradrenergic drugs thereon were studied. Noradrenaline (NA; in the presence of the uptake inhibitor desipramine) reduced synaptosomal 3H-NA release. Reduction of the concentration of calcium ions in the medium during K+ stimulation greatly enhanced the sensitivity of 3H-NA release to alpha-receptor-mediated inhibition. Under these conditions NA dose-dependently inhibited 3H-NA release from synaptosomes obtained from cortex or hypothalamus, but did not affect 3H-NA release from striatal (i.e dopaminergic) synaptosomes. Adrenaline, clonidine and oxymetazoline potently inhibited 3H-NA release from cortex synaptosomes at concentrations in the nanomolar range. Phentolamine by itself did not affect synaptosomal 3H-NA release, but antagonized the inhibitory effects of both noradrenaline and adrenaline. The data obtained further substantiate the hypothesis that the alpha-receptors mediating a local negative feedback control of NA release are localized on the varicosities of central noradrenergic neurons, Furthermore, noradrenergic nerve terminals in the hypothalamus appear to be less senstive to alpha-receptor-mediate...Continue Reading


Oct 1, 1988·Neurochemical Research·R AllinJ J Taljaard
Aug 24, 1999·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·M R Bennett
Mar 5, 1981·European Journal of Pharmacology·L HedlerK Starke
Feb 1, 1989·Brain Research Bulletin·M MiyazakiG B Baker
Jan 1, 1984·Annals of the New York Academy of Sciences·M L Dubocovich
Feb 22, 1993·The Journal of Comparative Neurology·A P NicholasT Hökfelt
Jan 1, 1990·Annals of the New York Academy of Sciences·B Scatton
Aug 1, 1989·Journal of the American Geriatrics Society·A AdunskyM Rabinowitz
May 1, 1986·Acta Pharmacologica Et Toxicologica·R VirtanenM Kaisila


Sep 1, 1977·Naunyn-Schmiedeberg's Archives of Pharmacology·H D TaubeE Borowski
Oct 1, 1976·European Journal of Pharmacology·R K Dismukes, A H Mulder
Sep 1, 1977·Naunyn-Schmiedeberg's Archives of Pharmacology·K DismukesA H Mulder
Jun 27, 1978·Naunyn-Schmiedeberg's Archives of Pharmacology·A H MulderF Hogenboom
Jan 1, 1971·Acta Physiologica Scandinavica. Supplementum·L O Farnebo, B Hamberger
Aug 24, 1973·Naunyn-Schmiedeberg's Archives of Pharmacology·K Starke, H Montel
Jan 1, 1974·Naunyn-Schmiedeberg's Archives of Pharmacology·W Kehr
Mar 1, 1972·Journal of Neurochemistry·R J Baldessarini, M Vogt

Related Concepts

Cortex Bone Disorders
Adrenal Cortex Diseases
Calcium ion

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.